Demystifying pharma science: Batch v/s continuous manufacturing – choosing the right approach Read more
IGNAZ trial interim results highlight HI-Bio’s potential to differentiate in IgAN space: GlobalData Read more
JJP Biologics to execute in-human clinical trial of Anti-Inflammatory mAb JJP-1212 (anti-CD89) Read more